Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Kuypers, Dirk [VerfasserIn]   i
 Meur, Yannick Le [VerfasserIn]   i
 Cantarovich, Marcelo [VerfasserIn]   i
 Tredger, Michael J. [VerfasserIn]   i
 Tett, Susan E. [VerfasserIn]   i
 Cattaneo, Dario [VerfasserIn]   i
 Tönshoff, Burkhard [VerfasserIn]   i
 Holt, David W. [VerfasserIn]   i
 Chapman, Jeremy [VerfasserIn]   i
 Gelder, Teun van [VerfasserIn]   i
Titel:Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation
Verf.angabe:Dirk R.J. Kuypers, Yannick Le Meur, Marcelo Cantarovich, Michael J. Tredger, Susan E. Tett, Dario Cattaneo, Burkhard Tönshoff, David W. Holt, Jeremy Chapman, Teun van Gelder, for The Transplantation Society (TTS) Consensus Group on TDM of Mpa
E-Jahr:2010
Jahr:February 2010
Umfang:18 S.
Fussnoten:Gesehen am 09.03.2023 ; DOI funktioniert nicht
Titel Quelle:Enthalten in: American Society of NephrologyClinical journal of the American Society of Nephrology
Ort Quelle:Washington, DC : American Society of Nephrology, 2006
Jahr Quelle:2010
Band/Heft Quelle:5(2010), 2 vom: Feb., Seite 341-358
ISSN Quelle:1555-905X
Abstract:With the increasing use of mycophenolic acid (MPA) in solid organ transplantation, the need for more accurate drug dosing has become evident. Personalized immunosuppressive therapy requires better strategies for avoidance of drug-related toxicity while maintaining efficacy. Few studies have assessed the clinical usefulness of therapeutic drug monitoring (TDM) of MPA in solid organ transplantation in a prospective way, and they have produced opposing results. To provide clinicians with an objective and balanced clinical interpretation of the current scientific evidence on TDM of MPA, a consensus meeting involving 47 experts from around the world was commissioned by The Transplantation Society and held in Rome on November 20 to 21, 2008. The goal of this consensus meeting was to offer information to transplant practitioners on clinically relevant pharmacokinetic characteristics of MPA, to rationalize the basis for currently advised target exposure ranges for MPA in various types of organ transplantation, and to summarize available methods for application of MPA TDM in clinical practice. Although this consensus report does not evaluate the final role of MPA TDM in transplantation, it seeks to examine the current scientific evidence for concentration-controlled dosing of MPA.
DOI:doi:10.2215/CJN.07111009
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.2215/CJN.07111009
 Volltext: https://journals.lww.com/cjasn/pages/articleviewer.aspx?year=2010&issue=02000&article=00030&type=Fulltext
 DOI: https://doi.org/10.2215/CJN.07111009
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1838723633
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69049955   QR-Code
zum Seitenanfang